While the baseline levels of IL-1β in patients with MDD were higher than those in healthy individuals (p = 0.03), the levels of this cytokine after 8 weeks of treatment with venlafaxine (W8)—in contrast to the study by Chen et al. [19]—increased [40]. Here, IL1B is linked to major depressive disorder.